Viridian Therapeutics (VRDN) Earnings Date, Estimates & Call Transcripts

$13.45
-1.18 (-8.07%)
(As of 05/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 8)
-$0.79 Beat By $0.28
Consensus EPS
(May. 8)
-$1.07
Skip Charts & View Estimated and Actual Earnings Data

VRDN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VRDN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Viridian Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244($0.99)($0.89)($0.93)
Q2 20245($0.90)($0.80)($0.83)
Q3 20245($1.10)($0.80)($0.94)
Q4 20245($1.17)($0.81)($0.92)
FY 202419($4.16)($3.30)($3.63)
Q1 20251($0.93)($0.93)($0.93)
Q2 20251($0.97)($0.97)($0.97)
Q3 20251($0.92)($0.92)($0.92)
Q4 20251($0.95)($0.95)($0.95)
FY 20254($3.77)($3.77)($3.77)

VRDN Earnings Date and Information

Viridian Therapeutics last issued its earnings data on May 8th, 2024. The reported ($0.79) earnings per share for the quarter, beating analysts' consensus estimates of ($1.07) by $0.28. The business earned $0.07 million during the quarter, compared to analyst estimates of $0.09 million. Its revenue for the quarter was down 26.5% on a year-over-year basis. Viridian Therapeutics has generated ($4.50) earnings per share over the last year (($4.50) diluted earnings per share). Earnings for Viridian Therapeutics are expected to decrease in the coming year, from ($3.61) to ($3.84) per share. Viridian Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Viridian Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
Estimated)
------- 
5/8/2024Q1 2024($1.07)($0.79)+$0.28($0.79)$0.09 million$0.07 million      
2/27/2024Q4 2023($0.98)($1.35)($0.37)($1.35)$0.15 million$0.07 million
11/13/2023Q3 2023($1.22)($1.09)+$0.13($1.09)$0.28 million$0.07 million
8/8/2023Q2 2023($1.26)($1.27)($0.01)($1.27)$0.25 million$0.07 million
5/9/2023Q1 2023($1.00)($1.61)($0.61)($1.61)$0.10 million$0.10 million    
3/8/2023Q4 2022($0.72)($1.13)($0.41)($1.13)$0.46 million$0.11 million    
11/14/2022Q3 2022($0.87)($0.86)+$0.01($0.86)$0.52 million$1.20 million
8/15/2022Q2 2022($0.86)($1.06)($0.20)($1.06)$0.70 million$0.26 million      
5/12/2022Q1 2022($0.92)($0.98)($0.06)($0.98)$0.65 million$0.22 million    
3/10/2022Q4 2021($0.85)($1.32)($0.47)($1.32)$0.75 million$0.21 million    
11/4/2021Q3 2021($1.25)($1.25)-($1.25)$1.00 million$0.21 million
8/11/2021Q2 2021($1.36)($2.21)($0.85)($2.21)-$1.09 million

Viridian Therapeutics Earnings - Frequently Asked Questions

When is Viridian Therapeutics's earnings date?

Viridian Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on VRDN's earnings history.

Did Viridian Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Viridian Therapeutics (NASDAQ:VRDN) reported ($0.79) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.07) by $0.28. Learn more on analysts' earnings estimate vs. VRDN's actual earnings.

How can I listen to Viridian Therapeutics's earnings conference call?

The conference call for Viridian Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Viridian Therapeutics's conference call transcript?

The conference call transcript for Viridian Therapeutics's latest earnings report can be read online. Read Transcript

How can I view Viridian Therapeutics's earnings report?

Viridian Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Viridian Therapeutics generate each year?

Viridian Therapeutics (NASDAQ:VRDN) has a recorded annual revenue of $310,000.00.

How much profit does Viridian Therapeutics generate each year?

Viridian Therapeutics (NASDAQ:VRDN) has a recorded net income of -$237.73 million. VRDN has generated -$4.50 earnings per share over the last four quarters.

What is Viridian Therapeutics's EPS forecast for next year?

Viridian Therapeutics's earnings are expected to decrease from ($3.61) per share to ($3.84) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:VRDN) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners